Protective role of AT2 and B1 receptors in kinin B2-receptor-knockout mice with myocardial infarction

Clinical Science

Volumn 124, Issue 2, 2013, Pages 87-96

  Xu, Jiang ^a   Carretero, Oscar A ^a   Zhu, Liping ^a   Shesely, Edward G ^a   Rhaleb, Nour Eddine ^a   Dai, Xiangguo ^a   Wang, Luchen ^a   Yang, James J ^a   Yang, Xiao Ping ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Angiotensin II type 2 receptor (AT2 receptor); B1 kinin receptor; B2 kinin receptor; Heart failure; Inflammation; Myocardial infarction; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; BRADYKININ B1 RECEPTOR; COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; CARDIOTONIC AGENT; CREATININE; IMIDAZOLE DERIVATIVE; NITRIC OXIDE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; ANIMAL; BLOOD PRESSURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ECHOCARDIOGRAPHY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; URINE;

ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CREATININE; ECHOCARDIOGRAPHY; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NITRIC OXIDE; PYRIDINES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84871876979     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120341     Document Type: Article

References (45)

1. Cohn, J. N. and Tognoni, G. (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med. 345, 1667-1675
2. Yusuf, S., Teo, K., Anderson, C., Pogue, J., Dyal, L., Copland, I., Schumacher, H., Dagenais, G. and Sleight, P. (2008) Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 372, 1174-1183
3. 2 kinin receptor gene knockout mice. Circ. Res. 88, 1072-1079
4. 1 antagonists in mice. Hypertension 40, 244-250
5. 1 receptor blockade. J. Mol. Cell. Cardiol. 37, 1023-1030
6. Yayama, K. and Okamoto, H. (2008) Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide. Int. Immunopharmacol. 8, 312-318
7. Tsutsumi, Y., Matsubara, H., Masaki, H., Kurihara, H., Murasawa, S., Takai, S., Miyazaki, M., Nozawa, Y., Ozono, R., Nakagawa, K. et al. (1999) Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104, 925-935
8. 1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension 45, 747-753
9. 1-receptor expression after myocardial infarction. Br. J. Pharmacol. 129, 1537-1538
10. Liu, Y. H., Yang, X. P., Shesely, E. G., Sankey, S. S. and Carretero, O. A. (2004) Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure. J. Am. Coll. Cardiol. 43, 1473-1480
11. 1 bradykinin receptor in normotension and hypertension. Circ. Res. 88, 275-281
12. Kakoki, M., Sullivan, K. A., Backus, C., Hayes, J. M., Oh, S. S., Hua, K., Gasim, A. M., Tomita, H., Grant, R., Nossov, S. B. et al. (2010) Lack of both bradykininB1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 107, 10190-10195
13. Shariat-Madar, Z., Mahdi, F., Warnock, M., Homeister, J. W., Srikanth, S., Krijanovski, Y., Murphey, L. J., Jaffa, A. A. and Schmaier, A. H. (2006) Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood 108, 192-199
14. Yang, F., Liu, Y. H., Yang, X. P., Xu, J., Kapke, A. and Carretero, O. A. (2002) Myocardial infarction and cardiac remodelling in mice. Exp. Physiol. 87, 547-555
15. Liu, Y. H., Yang, X. P., Sharov, V. G., Nass, O., Sabbah, H. N., Peterson, E. and Carretero, O. A. (1997) Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 99, 1926-1935
16. 2 receptor expression and signaling. Physiol. Genomics 2, 13-20
17. Duka, I., Duka, A., Kintsurashvili, E., Johns, C., Gavras, I. and Gavras, H. (2003) Mechanisms mediating the vasoactive effects of theB1 receptors of bradykinin. Hypertension 42, 1021-1025
18. 1 receptor antagonists containing α-methyl-L-phenylalanine: in vitro and in vivo antagonistic activities. Hypertension 33, 823-829
19. Xu, J., Carretero, O. A., Liao, T. D., Peng, H., Shesely, E. G., Xu, J., Liu, T. S., Yang, J. J., Reudelhuber, T. L. and Yang, X. P. (2010) Local angiotensin II aggravates cardiac remodeling in hypertension. Am. J. Physiol. Heart. Circ. Physiol. 299, H1328-H1338
20. Yang, X. P., Liu, Y. H., Rhaleb, N. E., Kurihara, N., Kim, H. E. and Carretero, O. A. (1999) Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am. J. Physiol. Heart. Circ. Physiol. 277, H1967-H1974
21. Xu, J., Carretero, O. A., Lin, C. X., Cavasin, M. A., Shesely, E. G., Yang, J. J., Reudelhuber, T. L. and Yang, X. P. (2007) Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. Am. J. Physiol. Heart. Circ. Physiol. 293, H1900-H1907
22. Zhan, E., Keimig, T., Xu, J., Peterson, E., Ding, J., Wang, F. and Yang, X. P. (2008) Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction. Exp. Physiol. 93, 982-993
23. Moncada, S. and Higgs, A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012
24. Xu, J., Carretero, O. A., Liu, Y. H., Yang, F., Shesely, E. G., Oja-Tebbe, N. and Yang, X. P. (2004) Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure. J. Card. Failure 10, 83-89
25. 2 receptor- and tissue kallikrein-deficient mice. Hypertension 40, 90-95
26. 2 receptor knockout mice. Circulation 100, 2359-2365
27. 2 receptor knockout mice. Hypertension 41, 1151-1155
28. Duka, A., Kintsurashvili, E., Duka, I., Ona, D., Hopkins, T. A., Bader, M., Gavras, I. and Gavras, H. (2008) Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kininB1 and B2 receptors. Hypertension 51, 1352-1357
29. Tan, Y., Keum, J. S., Wang, B., McHenry, M. B., Lipsitz, S. R. and Jaffa, A. A. (2007) Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 293, F1026-F1035
30. 1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice. Exp. Physiol. 94, 322-329
31. 1 blockade after experimental myocardial infarction. Cardiovasc. Res. 61, 559-569
32. Schulze-Topphoff, U., Prat, A., Prozorovski, T., Siffrin, V., Paterka, M., Herz, J., Bendix, I., Ifergan, I., Schadock, I., Mori, M. A. et al. (2009) Activation of kinin receptorB1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nat. Med 15, 788-793
33. Merino, V. F., Todiras, M., Mori, M. A., Sales, V. M., Fonseca, R. G., Saul, V., Tenner, K., Bader, M. and Pesquero, J. B. (2009) Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kininB1 receptor and apolipoprotein E. J. Mol. Med. 87, 953-963
34. 1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice. Int. Immunopharmacol. 2, 815-822
35. Yin, H., Chao, J., Bader, M. and Chao, L. (2007) Differential role of kininB1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides 28, 1383-1389
36. Kehat, I. and Molkentin, J. D. (2010) Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann. N. Y. Acad Sci. 1188, 96-102
37. Chao, J., Li, H. J., Yao, Y. Y., Shen, B., Gao, L., Bledsoe, G. and Chao, L. (2007) Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension 49, 490-497
38. Cellier, E., Mage, M., Duchêne, J., Pécher, C., Couture, R., Bascands, J. L. and Girolami, J. P. (2003) Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation. Am. J. Physiol. Renal. Physiol. 284, F282-F292
39. Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H., Schoenhoff, F., Bedja, D., Chen, Y., Modiri, A. N., Judge, D. P. and Dietz, H. C. (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332, 361-365
40. Bove, C. M., Yang, Z., Gilson, W. D., Epstein, F. H., French, B. A., Berr, S. S., Bishop, S. P., Matsubara, H., Carey, R. M. and Kramer, C. M. (2004) Nitric oxide mediates benefits of angiotensin II type 2 receptor overexpression during post-infarct remodeling. Hypertension 43, 680-685
41. Kakoki, M., McGarrah, R. W., Kim, H. S. and Smithies, O. (2007) BradykininB1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 104, 7576-7581
42. Zhu, L., Carretero, O. A., Liao, T. D., Harding, P., Li, H., Sumners, C. and Yang, X. P. (2010) Role of prolylcarboxypeptidase in angiotensin II type 2 receptor-mediated bradykinin release in mouse coronary artery endothelial cells. Hypertension 56, 384-390
43. Moniwa, N., Agata, J., Hagiwara, M., Ura, N. and Shimamoto, K. (2006) The role of bradykininB1 receptor on cardiac remodeling in stroke-prone spontaneously hypertensive rats (SHR-SP). Biol. Chem. 387, 203-209
44. Ying, W. Z. and Sanders, P. W. (2003) The interrelationship between TGF-β1 and nitric oxide is altered in salt-sensitive hypertension. Am. J. Physiol. Renal. Physiol. 285, F902-F908
45. Hayashida, T., Decaestecker, M. and Schnaper, H. W. (2003) Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-β-dependent responses in human mesangial cells. FASEB J. 17, 1576-1578